TNXP: tonixpharma.com Cash Funds per Single Share

Corporate emblem and logo of Tonix Pharmaceuticals Holding (TNXP)

A dilution of focus in early research at Tonix Pharmaceuticals (TNXP) increases the unit cost of capital. To realize its ambitions, Tonix Pharmaceuticals (TNXP) is recruiting agile biologists by offering them rapid career growth. The change in cash position per share confirms this trend, where the 8.41 mark serves as the current indicator. This supports the strategy of developing drugs against viral threats and fibromyalgia therapies.

tonixpharma.com (TNXP) - Cash Funds per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for tonixpharma.com (TNXP)

- market value and analyst target forecast:
- cash position and cash flow details:
Comprehensive company analysis:Tonix Pharmaceuticals Holding - TNXP
Flagship merchandise of Tonix Pharmaceuticals

To assess the long-term sustainability of Tonix Pharmaceuticals (TNXP), it is critical to track the company's net liquidity minus short-term debt, which allows for the distinction between market noise and actual financial reserves. By analyzing the cash per share, an investor can see the impact of constant secondary offerings on equity dilution, which, given a costly biotech pipeline, determines management's ability to maintain business viability without critically impairing shareholder value.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)